{"id":"W2935541805","doi":"10.1016/s1470-2045(19)30029-4","title":"Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":537,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; BRCA mutation; Oncology; Progressive disease; Chemotherapy; Progression-free survival; Population; Phases of clinical research; Carboplatin; Combination therapy; Surgery; Gastroenterology; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004694136,0.0002520478,0.001257124,0.00007377286,0.00007872333,0.00002044171,0.0003348143,0.0001907979,0.001321848],"category_scores_gemma":[0.00003485547,0.0001656186,0.0001200971,0.0001873798,0.0001532434,0.00007734291,0.00003460658,0.0001366985,0.00003799704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006964681,"about_ca_system_score_gemma":0.0004957653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004103262,"about_ca_topic_score_gemma":0.0002291894,"domain_scores_codex":[0.9981915,0.0002230188,0.0005562513,0.0003878538,0.0001722263,0.0004691967],"domain_scores_gemma":[0.9980692,0.0005486693,0.0004282607,0.0006918242,0.0001598669,0.0001021786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7075873,0.02326378,0.0003626719,0.000117849,0.001269471,0.00001944347,0.002978139,0.0001194439,0.1236561,0.001597572,0.007833914,0.1311943],"study_design_scores_gemma":[0.5433815,0.03649398,0.00004203046,0.00006787481,0.0002166787,0.00001068652,0.00007202022,0.001340501,0.02303319,0.0005610614,0.3946285,0.0001520198],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9556818,0.001592967,0.0005653496,0.02727901,0.001913648,0.008377397,0.0003358841,0.0000790354,0.004174937],"genre_scores_gemma":[0.9699512,0.002940644,0.005932465,0.007960144,0.003465728,0.002719293,0.0001604646,0.0001032983,0.006766839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3867946,"threshold_uncertainty_score":0.9995911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2455515079193662,"score_gpt":0.4816545343169153,"score_spread":0.2361030263975491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}